| Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma (NCT02892019) | Novartis Pharmaceuticals | 2017-04-18 |
| Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients (NCT03055494) | Novartis Pharmaceuticals | 2017-04-18 |
| Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia (NCT02961218) | Novartis Pharmaceuticals | 2017-04-05 |
| Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy. (NCT03074357) | Novartis Pharmaceuticals | 2017-04-04 |
| Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis (NCT02745080) | Novartis Pharmaceuticals | 2017-04-03 |
| Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. (NCT02966353) | Novartis Pharmaceuticals | 2017-03-31 |
| Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis (NCT03020199) | Novartis Pharmaceuticals | 2017-03-27 |
| Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment (NCT03052517) | Novartis Pharmaceuticals | 2017-03-21 |
| A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies (NCT03096834) | Novartis Pharmaceuticals | 2017-03-20 |
| Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function (NCT02678000) | Novartis Pharmaceuticals | 2017-03-10 |
| Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation (NCT02913261) | Novartis Pharmaceuticals | 2017-03-10 |
| Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis (NCT03066609) | Novartis Pharmaceuticals | 2017-02-28 |
| A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma (NCT02974725) | Novartis Pharmaceuticals | 2017-02-24 |
| A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma (NCT02967692) | Novartis Pharmaceuticals | 2017-02-17 |
| Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) (NCT02955069) | Novartis Pharmaceuticals | 2017-02-14 |
| Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection (NCT02712983) | Novartis Pharmaceuticals | 2017-02-08 |
| Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes (NCT03005288) | Novartis Pharmaceuticals | 2017-02-01 |
| Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma. (NCT03063086) | Novartis Pharmaceuticals | 2017-01-21 |
| Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma (NCT02892344) | Novartis Pharmaceuticals | 2017-01-16 |
| Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne (NCT02998671) | Novartis Pharmaceuticals | 2016-12-22 |
| randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure (NCT02900378) | Novartis Pharmaceuticals | 2016-12-20 |
| Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment (NCT02873650) | Novartis Pharmaceuticals | 2016-12-20 |
| Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment (NCT02852239) | Novartis Pharmaceuticals | 2016-12-19 |
| Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis (NCT02888080) | Novartis Pharmaceuticals | 2016-12-19 |
| Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. (NCT02970669) | Novartis Pharmaceuticals | 2016-12-16 |
| Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (NCT02953938) | Novartis Pharmaceuticals | 2016-12-15 |
| Ribociclib (LEE011) Rollover Study for Continued Access (NCT02934568) | Novartis Pharmaceuticals | 2016-12-15 |
| A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors. (NCT02925104) | Novartis Pharmaceuticals | 2016-12-14 |
| Study of Secukinumab With 2 mL Pre-filled Syringes (NCT02748863) | Novartis Pharmaceuticals | 2016-12-12 |
| Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI (NCT02924727) | Novartis Pharmaceuticals | 2016-12-09 |
| Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma (NCT02756663) | Novartis Pharmaceuticals | 2016-12-01 |
| Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma (NCT01964235) | Novartis Pharmaceuticals | 2016-12-01 |
| Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery (NCT02961062) | Novartis Pharmaceuticals | 2016-12-01 |
| HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma (NCT02947152) | Novartis Pharmaceuticals | 2016-12-01 |
| Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC (NCT02941926) | Novartis Pharmaceuticals | 2016-11-30 |
| Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction (NCT02884206) | Novartis Pharmaceuticals | 2016-11-23 |
| Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease (NCT02980263) | Novartis Pharmaceuticals | 2016-11-15 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure (NCT02678312) | Novartis Pharmaceuticals | 2016-11-03 |
| Safety and Efficacy Study of SOM230 s.c. in Cluster Headache (NCT02619617) | Novartis Pharmaceuticals | 2016-10-31 |
| Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes. (NCT02887183) | Novartis Pharmaceuticals | 2016-10-25 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH (NCT02913105) | Novartis Pharmaceuticals | 2016-10-24 |
| Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer (NCT03096847) | Novartis Pharmaceuticals | 2016-10-24 |
| A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors (NCT02829723) | Novartis Pharmaceuticals | 2016-10-21 |
| A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors (NCT02705963) | Novartis Pharmaceuticals | 2016-10-20 |
| A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. (NCT02936102) | Novartis Pharmaceuticals | 2016-10-20 |
| Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis (NCT02896127) | Novartis Pharmaceuticals | 2016-10-18 |
| A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat (NCT02890069) | Novartis Pharmaceuticals | 2016-10-14 |
| An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes (NCT02911857) | Novartis Pharmaceuticals | 2016-10-03 |
| Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies (NCT02900651) | Novartis Pharmaceuticals | 2016-10-03 |
| Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease (NCT02697734) | Novartis Pharmaceuticals | 2016-10-03 |
| Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement (NCT02721966) | Novartis Pharmaceuticals | 2016-10-03 |
| Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis (NCT01649050) | Novartis Pharmaceuticals | 2016-10-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema (NCT02867735) | Novartis Pharmaceuticals | 2016-09-21 |
| Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis (NCT02792218) | Novartis Pharmaceuticals | 2016-09-20 |
| 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME. (NCT02878681) | Novartis Pharmaceuticals | 2016-09-01 |
| Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site (NCT02771210) | Novartis Pharmaceuticals | 2016-08-30 |
| Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. (NCT02792231) | Novartis Pharmaceuticals | 2016-08-26 |
| Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316 (NCT02878616) | Novartis Pharmaceuticals | 2016-08-26 |
| A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia (NCT02826642) | Novartis Pharmaceuticals | 2016-08-26 |
| A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib) (NCT02900664) | Novartis Pharmaceuticals | 2016-08-23 |
| Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) (NCT02662985) | Novartis Pharmaceuticals | 2016-08-22 |
| Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064 (NCT03918980) | Novartis Pharmaceuticals | 2016-08-18 |
| Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction (NCT02874794) | Novartis Pharmaceuticals | 2016-08-17 |
| Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation (NCT02720536) | Novartis Pharmaceuticals | 2016-08-16 |
| Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) (NCT02855164) | Novartis Pharmaceuticals | 2016-08-01 |
| Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas (NCT02740270) | Novartis Pharmaceuticals | 2016-07-22 |
| Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction. (NCT02768298) | Novartis Pharmaceuticals | 2016-07-12 |
| A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care (NCT02807857) | Novartis Pharmaceuticals | 2016-07-07 |
| Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors (NCT02703571) | Novartis Pharmaceuticals | 2016-06-29 |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies (NCT02807844) | Novartis Pharmaceuticals | 2016-06-29 |
| Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line (NCT05734053) | Novartis Pharmaceuticals | 2016-06-28 |
| Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo (NCT02798211) | Novartis Pharmaceuticals | 2016-06-27 |
| 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement (NCT02756650) | Novartis Pharmaceuticals | 2016-06-23 |
| Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis (NCT02826603) | Novartis Pharmaceuticals | 2016-06-22 |
| Rainbow Extension Study (NCT02640664) | Novartis Pharmaceuticals | 2016-06-16 |
| Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC (NCT02795429) | Novartis Pharmaceuticals | 2016-06-15 |
| A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) (NCT02720510) | Novartis Pharmaceuticals | 2016-06-14 |
| Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. (NCT02732119) | Novartis Pharmaceuticals | 2016-06-14 |
| Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers (NCT02734615) | Novartis Pharmaceuticals | 2016-06-14 |
| QVA Mechanistic Efficacy Study (Receptor Effects, Etc) (NCT02634983) | Novartis Pharmaceuticals | 2016-06-03 |
| Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome (NCT02775916) | Novartis Pharmaceuticals | 2016-06-01 |
| Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population (NCT02795416) | Novartis Pharmaceuticals | 2016-06-01 |
| Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis (NCT02763046) | Novartis Pharmaceuticals | 2016-05-31 |
| A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy. (NCT02663752) | Novartis Pharmaceuticals | 2016-05-30 |
| A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients (NCT02649218) | Novartis Pharmaceuticals | 2016-05-24 |
| PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada (NCT02957409) | Novartis Pharmaceuticals | 2016-05-20 |
| A Study of CLR325 in Chronic Stable Heart Failure Patients. (NCT02696967) | Novartis Pharmaceuticals | 2016-05-17 |
| Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01) (NCT02720107) | Novartis Pharmaceuticals | 2016-05-12 |
| NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. (NCT02703636) | Novartis Pharmaceuticals | 2016-05-09 |
| Ceritinib Rare Indications Study in ALK+ Tumors (NCT02465528) | Novartis Pharmaceuticals | 2016-05-06 |
| A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects (NCT02857868) | Novartis Pharmaceuticals | 2016-05-03 |
| A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention (NCT01617941) | Novartis Pharmaceuticals | 2016-05-01 |
| Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. (NCT02554890) | Novartis Pharmaceuticals | 2016-04-29 |
| Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis (NCT02696031) | Novartis Pharmaceuticals | 2016-04-29 |
| Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients (NCT02763644) | Novartis Pharmaceuticals | 2016-04-22 |
| Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT02605967) | Novartis Pharmaceuticals | 2016-04-20 |
| A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease (NCT02713256) | Novartis Pharmaceuticals | 2016-04-19 |
| A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. (NCT02711345) | Novartis Pharmaceuticals | 2016-04-15 |
| Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis (NCT02750592) | Novartis Pharmaceuticals | 2016-03-22 |
| A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. (NCT02752776) | Novartis Pharmaceuticals | 2016-03-17 |